CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 37 enrolled
Drug / intervention
Ibuprofen, Diphenhydramine and Aluminium MgS +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01293968
NCT01293968Phase 2Completed
CompareCT.gov

Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis

Qazvin University Of Medical Sciences·interventional·Posted Feb 11, 2011·Updated Jun 20, 2012

In Brief

A Phase 2 clinical trial evaluating Ibuprofen, Diphenhydramine and Aluminium MgS and Diphenhydramine and Aluminium MgS for Aphthous Stomatitis. Completed, enrolled 37 participants across 2 sites.

Detailed Summary

The intention of the study is to study the effects of Ibuprofen, Diphenhydramine and Aluminium MgS in decreasing the signs of recurrent aphthous stomatitis (RAS)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAphthous Stomatitis
CountriesIran
Collaborators--

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 11, 2011
Enrollment StartNov 1, 2010
Primary CompletionJan 1, 2011
Study CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.4 years ago

Interventions

Ibuprofen, Diphenhydramine and Aluminium MgSdrug

3 times daily for 3 days

Diphenhydramine and Aluminium MgSdrug

3 times daily for 3 days